Navigation Links
Industry leaders join together for historic Accelerating Cancer Cures Research Symposium
Date:3/6/2012

New York, NY (March 5, 2012) Today, the Damon Runyon Cancer Research Foundation held its first Accelerating Cancer Cures Research Symposium, focused on rebuilding the ranks of physician-scientists specially trained to translate laboratory discoveries into new cancer therapies. The event, held at Pfizer Inc headquarters, brought together academic scientists and other leading pharmaceutical companies, including Eli Lilly and Company, Celgene, Genentech, Merck, and Millennium: The Takeda Oncology Company.

The symposium is the first of its kind since Damon Runyon, a New York-based foundation, launched its Accelerating Cancer Cures program in June 2011. Accelerating Cancer Cures is a five-year, multi-million dollar project that will train a new generation of exceptional clinical investigators capable of translating the latest scientific discoveries into new diagnostics and therapeutics for cancer patients. The initiative also eliminates barriers to progress by fostering communication and collaboration between academia and industry. It is supported by some of the world's leading companies and The Pharmaceutical Research and Manufacturers of America (PhRMA).

"We risk losing tremendous ground in our effort to find cures for cancer if we cannot attract new talent and new ideas to clinical research," said Damon Runyon Cancer Research Foundation President and CEO Lorraine Egan when the program launched. "Our best hope for crucial breakthroughs to prevent, diagnose and treat cancer lies with the committed young scientists who will be able to pursue critical translational research thanks to this effort."

Scientists from the nation's leading research institutions, including the Dana-Farber Cancer Institute, Fred Hutchinson Cancer Research Center, Mayo Clinic, Memorial Sloan-Kettering Cancer Center, and the University of North Carolina, Chapel Hill, traveled to New York to attend.

Pfizer Vice President Jamey R. Skillings, MD, MSc, MBA, led a discussion on targeted therapies for cancer, and Celgene Vice President Rajesh Chopra, MD, PhD, chaired a session on immunotherapies. They were joined by twenty Damon Runyon-funded scientists.

The day ended with a panel discussion, moderated by Damon Runyon Chief Scientific Officer Yung S. Lie, PhD, about navigating the boundaries between industry and academia and overcoming barriers to collaboration and translational research.


'/>"/>

Contact: Todd Brogan
todd.brogan@damonrunyon.org
212-455-0552
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Related medicine news :

1. ClearWay Minnesota(SM) Shines a Spotlight on a Reinvented Tobacco Industry
2. Industry Recognizes the Regence Health Engine for Excellence in Creativity, Innovation and Information
3. Chocolate Industry Leaders Sign Agreement, Align on Path Towards Increasing Consumer Availability & Consistency of Beneficial Cocoa Flavanols
4. San Diego State University and BIOCOM Institute Receive $4.95 Million Grant: The BRIDGE Project, Linking Education to Employment in San Diegos Life Sciences Industry
5. Language Service Leader Expands to Meet Booming, Global Industry Demand.
6. Vestara and EXP Pharmaceutical Services Corp. Announce Partnership Making Available Industry's Only Automated Pharmaceutical Waste Management Solution to over 5,000 U.S. Hospitals
7. Pelosi, Senior Democrats Remarks at News Conference on Repealing Health Insurance Industry Anti-Trust Exemption
8. Researchers at No. 1-Ranked U.S. Childrens Hospital Work with Industry to Develop a Child Crash Dummy thats More True-to-Life
9. Innovative Medical Alert Device Sets a New Standard in PERS Industry
10. Dairy Industry Raises a Glass of Milk to Lets Move! Campaign
11. LG Electronics Provides a Dose of HD for the Healthcare Industry at HIMSS 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 2017 , ... Doctor C LLC, a company based out of Arizona that ... continue the marketing and distribution of its product, The Right C. , The Right ... absorption than traditional vitamin C supplements. At the trade show, Doctor C had the ...
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated ... Institute. For Betsy, the clinical trial has been life-saving as she has been ... , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard ...
(Date:1/20/2017)... ... ... account following a man who went on to support his country and serve the Lord. ... Haven, Florida and at the age of 5, his family moved to Pensacola Florida. In ... and got married right out of boot camp. , He and his wife raised ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: a moving ... is God’s Lighthouse” is the creation of published author, Gene Gaapf, a retired truck ... , “I have been writing since high school and have many different titles,” ...
(Date:1/19/2017)... , ... January 19, 2017 , ... Next week after ... be repealed by Congressional political games that circumvent health needs of over 30 million. ... capture the human anxieties and needs government public servants were suppose to prioritize. Interviews ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Research and Markets has announced the addition of the ... Amplifiers, Diagnostic Instruments), Sales Volume, Company Analysis and Forecast to ... ... Volume, Company Analysis and Forecast to 2022 provides a comprehensive ... The growing prevalence of hearing impairment coupled with an expanding ...
(Date:1/20/2017)... -- Wells Specialty Pharmacy announces the acquisitions and merger of ... Winter Park, Florida and Pharm-EZ Medical, LLC, ... been consolidated into the 3796 Howell Branch Road Facility. ... Chad Tomlinson , former Vice President of Operations, has ... Tomlinson is a Graduate of Florida State University and has ...
(Date:1/19/2017)... -- Report Details What can be expected ... to grow at the fastest rates? This visiongain report ... opportunities and prospects. Our 190-page report provides 124 ... in the industry and the future market prospects. Our ... all the major categories of the ophthalmic devices market. ...
Breaking Medicine Technology: